Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population

Jennifer D. Guo, Patrick Hlavacek, Lisa Rosenblatt, Allison Keshishian, Cristina Russ, Jack Mardekian, Mauricio Ferri, Tayla Poretta, Huseyin Yuce, Robert McBane

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population'. Together they form a unique fingerprint.

Medicine & Life Sciences